|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2005-1-25
|
|
pubmed:abstractText |
This multicenter phase II study evaluated feasibility, clinical efficacy, toxicity and pharmacokinetics of the combination of pegylated liposomal doxorubicin (PLD) and vinorelbine (VNR) in patients with platinum-paclitaxel pretreated recurrent ovarian cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
300-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15668288-Adult,
pubmed-meshheading:15668288-Aged,
pubmed-meshheading:15668288-Antibiotics, Antineoplastic,
pubmed-meshheading:15668288-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15668288-Carcinoma,
pubmed-meshheading:15668288-Disease Progression,
pubmed-meshheading:15668288-Doxorubicin,
pubmed-meshheading:15668288-Female,
pubmed-meshheading:15668288-Humans,
pubmed-meshheading:15668288-Liposomes,
pubmed-meshheading:15668288-Middle Aged,
pubmed-meshheading:15668288-Neoplasm Recurrence, Local,
pubmed-meshheading:15668288-Ovarian Neoplasms,
pubmed-meshheading:15668288-Prospective Studies,
pubmed-meshheading:15668288-Survival Analysis,
pubmed-meshheading:15668288-Vinblastine
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Clinical and pharmacokinetic phase II study of pegylated liposomal doxorubicin and vinorelbine in heavily pretreated recurrent ovarian carcinoma.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Gynecologic Oncology Unit, University of Turin, Via Ventimiglia 3, 10126 Turin, Italy. dhocc@libero.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
